Aller au contenu principal
Institution scientifique

Eternity Bioscience (United States)

Cranbury, US, company

243Publications signalées
7520Citations signalées
12Thèmes principaux

Les principaux domaines

Research Data Management PracticesEnvironmental DNA in Biodiversity StudiesParkinson's Disease Mechanisms and TreatmentsCancer Immunotherapy and BiomarkersSpine and Intervertebral Disc PathologyMelanoma and MAPK PathwaysPlanarian Biology and ElectrostimulationBone Tissue Engineering MaterialsDrug Solubulity and Delivery SystemsElectromagnetic Fields and Biological EffectsAnalytical Methods in PharmaceuticalsEnvironmental Monitoring and Data Management

L’évolution annuelle

1970 1
1976 2
1977 1
1978 1
1981 1
1997 4
1998 3
2000 3
2001 2
2002 3
2003 19
2004 6
2005 7
2006 6
2007 2
2008 2
2009 5
2012 3
2013 2
2015 4
2016 3
2018 6
2019 3
2020 9
2021 14
2022 19
2023 5
2024 13
2025 9
2026 26

Les publications récentes

Accès ouvert 2026 article OpenAlex

eDNAqua-Plan Deliverable 16: Roadmap for implementation of the optimal system(s) /workflow(s)

Tim Collart, Carlijn Adriënne Koole, Oonagh McMeel, Katrina M. Exter et autres

This Roadmap summarises significant outputs generated throughout the three-year eDNAqua-Plan project. These outputs, particularly the eDNAqua-Plan Blueprint, contain the detail and justification that guided the development of this Roadmap. Readers are advised to refer to the relevant documents for details, all of …

Afrique du Sud, be, fr, gb, de, fi, us (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 article OpenAlex

eDNAqua-Plan Deliverable 16: Roadmap for implementation of the optimal system(s) /workflow(s)

Tim Collart, Carlijn Adriënne Koole, Oonagh McMeel, Katrina M. Exter et autres

This Roadmap summarises significant outputs generated throughout the three-year eDNAqua-Plan project. These outputs, particularly the eDNAqua-Plan Blueprint, contain the detail and justification that guided the development of this Roadmap. Readers are advised to refer to the relevant documents for details, all of …

Afrique du Sud, be, fr, gb, de, fi, us (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 article OpenAlex

eDNAqua-Plan Deliverable 14: Blueprint for future systems/workflow(s)

Katrina M. Exter, Emilie Boulanger, Paolo Tagliolato, Stephen K. Formel et autres

The eDNAqua-Plan Blueprint presents a comprehensive vision for a future FAIR – and in particular interoperable, machine-actionable – digital ecosystem for environmental DNA (eDNA) and its omics and biodiversity data and metadata. The report synthesises outputs from the previous eDNAqua-Plan work package …

be, fr, it, us, fi, de, il, es, gb (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 article OpenAlex

AI-driven identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption

Yihe Li, Qihang Wu, Shengnan Qin, Ruth Seeber et autres

Current antiresorptive therapies reduce bone loss by eliminating osteoclasts or inhibiting their formation. However, these approaches could disrupt osteoclast-osteoblast communication and cause serious complications with long-term usage. There is a need for developing new therapies that selectively inhibit resorptive function, while preserving …

au, cn, us, gb (code pays fourni par la source)

0 citations Journal of Bone and Mineral Research
Accès ouvert 2026 article OpenAlex

eDNAqua-Plan Deliverable 14: Blueprint for future systems/workflow(s)

Katrina M. Exter, Emilie Boulanger, Paolo Tagliolato, Stephen K. Formel et autres

The eDNAqua-Plan Blueprint presents a comprehensive vision for a future FAIR – and in particular interoperable, machine-actionable – digital ecosystem for environmental DNA (eDNA) and its omics and biodiversity data and metadata. The report synthesises outputs from the previous eDNAqua-Plan work package …

be, fr, it, us, fi, de, il, es, gb (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
2026 article OpenAlex

1514-P: Real-World Barriers Contributing to Clinical Inertia in Type 2 Diabetes: A Pharmacist-Focused Educational Outcomes Study

DIANA ISAACS, FARAH (ROSE) BUSZKA, BRIANNA WINTERS, MEAGAN BRIXIE

Introduction and Objective: The growing prevalence of diabetes requires responsive management. The objectives of this study were to characterize real-world barriers contributing to inertia in T2D among pharmacists and to evaluate changes in confidence and competence following a CE program. Methods: Local …

us (code pays fourni par la source)

0 citations Diabetes
Accès ouvert 2026 article OpenAlex

Development of a translational murine model for antibody-drug conjugate-induced interstitial lung disease

Suresh Anaganti, Arti Bhujade, Steven Murkli, Zachary Sparta et autres

, is transforming HER2+ breast cancer treatment but is linked to severe off-target toxicity, notably interstitial lung disease (ILD), a serious and mechanistically unresolved adverse event. The preclinical prediction of ILD, however, remains poor and largely dependent on non-human primates (NHP). Here, …

us (code pays fourni par la source)

1 citation npj Precision Oncology
Accès ouvert 2026 dataset OpenAlex

Bulk RNA sequencing of human post-mortem brain tissue from Parkinson's disease and control donors

Christina E. Toomey, Aine Fairbrother-Browne, Jonathan Brenton, Melissa Grant‐Peters et autres

This Zenodo deposit contains a publicly available description of the Dataset: Title: "Bulk RNA sequencing of human post-mortem brain tissue from Parkinson's disease and control donors". Description: Bulk RNA-seq data from 234 samples derived from PMDBS samples across Substantia Nigra, Caudate, Putamen, …

gb, us, it, pk (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 article OpenAlex

Autologous Ex Vivo Lentiviral Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I Provides Sustained Efficacy with a Favorable Safety Profile

Claire Booth, Julián Sevilla, Elena Almarza, Caroline Y. Kuo et autres

Background Severe leukocyte adhesion deficiency-I (LAD-I) results from biallelic deleterious ITGB2 variants leading to deficient/defective CD18 leukocyte expression and impaired endothelial adhesion and extravasation. Children with <2% of normal CD18 neutrophil expression experience recurrent, life-threatening bacterial and fungal infections, and extensive mortality. …

gb, es, us, de (code pays fourni par la source)

1 citation Journal of Human Immunity

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.